Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stroke | 74 | 2024 | 9975 | 3.350 |
Why?
|
Cerebral Angiography | 33 | 2019 | 1285 | 3.310 |
Why?
|
Diffusion Magnetic Resonance Imaging | 38 | 2021 | 2739 | 2.720 |
Why?
|
Brain Ischemia | 35 | 2024 | 3264 | 2.280 |
Why?
|
Magnetic Resonance Angiography | 18 | 2019 | 1444 | 1.910 |
Why?
|
Cerebral Infarction | 20 | 2020 | 1011 | 1.660 |
Why?
|
Tomography, X-Ray Computed | 58 | 2023 | 20121 | 1.470 |
Why?
|
Brain | 81 | 2024 | 26345 | 1.430 |
Why?
|
Magnetic Resonance Imaging | 97 | 2024 | 35409 | 1.390 |
Why?
|
Cerebral Arteries | 8 | 2018 | 494 | 1.070 |
Why?
|
Radiology | 12 | 2023 | 2099 | 1.040 |
Why?
|
Diagnostic Imaging | 9 | 2021 | 3503 | 1.040 |
Why?
|
Infarction | 3 | 2024 | 244 | 1.030 |
Why?
|
Triage | 6 | 2021 | 977 | 0.840 |
Why?
|
Cerebrovascular Disorders | 11 | 2019 | 1504 | 0.830 |
Why?
|
Brain Diseases | 8 | 2024 | 1558 | 0.800 |
Why?
|
Cerebral Revascularization | 3 | 2013 | 238 | 0.770 |
Why?
|
Thrombolytic Therapy | 11 | 2021 | 2162 | 0.770 |
Why?
|
Cerebrovascular Circulation | 21 | 2017 | 2732 | 0.700 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2019 | 66 | 0.670 |
Why?
|
Vascular Diseases | 3 | 2019 | 1161 | 0.640 |
Why?
|
Neuroradiography | 4 | 2016 | 70 | 0.620 |
Why?
|
Central Nervous System Diseases | 3 | 2019 | 518 | 0.600 |
Why?
|
Tuberculosis, Meningeal | 2 | 2014 | 45 | 0.590 |
Why?
|
Perfusion Imaging | 6 | 2015 | 195 | 0.580 |
Why?
|
Ischemic Attack, Transient | 8 | 2013 | 934 | 0.580 |
Why?
|
Reperfusion | 4 | 2014 | 283 | 0.580 |
Why?
|
Impulsive Behavior | 1 | 2018 | 316 | 0.550 |
Why?
|
Internship and Residency | 6 | 2023 | 5787 | 0.540 |
Why?
|
Neuromyelitis Optica | 1 | 2019 | 252 | 0.530 |
Why?
|
Meninges | 1 | 2017 | 190 | 0.520 |
Why?
|
Echo-Planar Imaging | 6 | 2022 | 659 | 0.520 |
Why?
|
Head Injuries, Closed | 3 | 2010 | 139 | 0.510 |
Why?
|
Cerebral Hemorrhage | 14 | 2011 | 2647 | 0.510 |
Why?
|
Intracranial Hemorrhages | 5 | 2023 | 855 | 0.500 |
Why?
|
Gadolinium | 8 | 2021 | 950 | 0.490 |
Why?
|
Nervous System Diseases | 3 | 2019 | 1619 | 0.480 |
Why?
|
Humans | 233 | 2024 | 743811 | 0.470 |
Why?
|
Image Interpretation, Computer-Assisted | 8 | 2020 | 3320 | 0.460 |
Why?
|
Frontal Lobe | 2 | 2018 | 1395 | 0.430 |
Why?
|
Confusion | 6 | 2022 | 275 | 0.420 |
Why?
|
Glioblastoma | 5 | 2014 | 3480 | 0.420 |
Why?
|
Aged | 114 | 2022 | 163178 | 0.420 |
Why?
|
Burnout, Professional | 1 | 2021 | 694 | 0.420 |
Why?
|
Radiology Department, Hospital | 3 | 2021 | 412 | 0.420 |
Why?
|
Aneurysm, Ruptured | 2 | 2015 | 452 | 0.410 |
Why?
|
Diagnosis, Differential | 33 | 2022 | 12954 | 0.410 |
Why?
|
Contrast Media | 18 | 2017 | 5301 | 0.400 |
Why?
|
Diffuse Axonal Injury | 4 | 2004 | 49 | 0.390 |
Why?
|
Brain Neoplasms | 13 | 2017 | 8856 | 0.390 |
Why?
|
Intraoperative Care | 1 | 2014 | 767 | 0.370 |
Why?
|
Aged, 80 and over | 67 | 2020 | 57744 | 0.360 |
Why?
|
Carotid Stenosis | 4 | 2012 | 854 | 0.360 |
Why?
|
Middle Aged | 109 | 2022 | 213241 | 0.360 |
Why?
|
Coma | 3 | 2023 | 475 | 0.360 |
Why?
|
Sinus Thrombosis, Intracranial | 3 | 2010 | 103 | 0.350 |
Why?
|
Male | 135 | 2022 | 349776 | 0.350 |
Why?
|
Sensitivity and Specificity | 28 | 2017 | 14714 | 0.350 |
Why?
|
Executive Function | 1 | 2018 | 1361 | 0.340 |
Why?
|
Algorithms | 11 | 2023 | 13869 | 0.330 |
Why?
|
Acute Disease | 20 | 2017 | 7150 | 0.320 |
Why?
|
Meningeal Neoplasms | 3 | 2014 | 1241 | 0.320 |
Why?
|
Headache | 4 | 2022 | 1224 | 0.320 |
Why?
|
Infusions, Intra-Arterial | 1 | 2008 | 236 | 0.320 |
Why?
|
Education, Medical, Graduate | 4 | 2023 | 2291 | 0.310 |
Why?
|
Image Processing, Computer-Assisted | 17 | 2023 | 8939 | 0.310 |
Why?
|
Skull Neoplasms | 2 | 2007 | 173 | 0.310 |
Why?
|
Intracranial Aneurysm | 2 | 2015 | 1197 | 0.310 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2134 | 0.300 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2008 | 114 | 0.300 |
Why?
|
Guidelines as Topic | 1 | 2014 | 1404 | 0.290 |
Why?
|
Glasgow Coma Scale | 4 | 2022 | 570 | 0.290 |
Why?
|
Female | 127 | 2022 | 380020 | 0.290 |
Why?
|
Patient Selection | 6 | 2017 | 4210 | 0.280 |
Why?
|
Image Enhancement | 8 | 2016 | 2915 | 0.280 |
Why?
|
Reproducibility of Results | 26 | 2020 | 19894 | 0.270 |
Why?
|
Brain Infarction | 4 | 2012 | 299 | 0.270 |
Why?
|
Brain Edema | 3 | 2022 | 617 | 0.270 |
Why?
|
Radiology Information Systems | 3 | 2020 | 523 | 0.260 |
Why?
|
Health Expenditures | 2 | 2015 | 2348 | 0.260 |
Why?
|
Consciousness Disorders | 2 | 2021 | 418 | 0.260 |
Why?
|
Thrombectomy | 3 | 2021 | 680 | 0.260 |
Why?
|
Basilar Artery | 3 | 2017 | 200 | 0.250 |
Why?
|
Radiography | 11 | 2023 | 7010 | 0.250 |
Why?
|
Severity of Illness Index | 14 | 2021 | 15526 | 0.250 |
Why?
|
Neck Injuries | 2 | 2010 | 152 | 0.240 |
Why?
|
Retrospective Studies | 39 | 2023 | 77410 | 0.240 |
Why?
|
Tomography, Spiral Computed | 1 | 2006 | 280 | 0.240 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2011 | 1184 | 0.240 |
Why?
|
Perfusion | 6 | 2021 | 1359 | 0.230 |
Why?
|
Fibrinolytic Agents | 2 | 2012 | 2159 | 0.230 |
Why?
|
Artifacts | 9 | 2023 | 1904 | 0.230 |
Why?
|
Muscle Weakness | 4 | 2022 | 413 | 0.230 |
Why?
|
Artificial Intelligence | 3 | 2021 | 2210 | 0.230 |
Why?
|
Diffusion | 10 | 2011 | 831 | 0.230 |
Why?
|
Personnel Selection | 1 | 2005 | 190 | 0.230 |
Why?
|
Angiography | 2 | 2009 | 1638 | 0.230 |
Why?
|
Eclampsia | 2 | 2009 | 58 | 0.230 |
Why?
|
Emergency Medical Services | 1 | 2015 | 1917 | 0.220 |
Why?
|
Glioma | 3 | 2014 | 3401 | 0.220 |
Why?
|
Predictive Value of Tests | 15 | 2015 | 15067 | 0.220 |
Why?
|
Functional Laterality | 1 | 2010 | 2280 | 0.220 |
Why?
|
Fatal Outcome | 10 | 2022 | 1851 | 0.220 |
Why?
|
Tissue Survival | 1 | 2003 | 118 | 0.220 |
Why?
|
Blood Volume | 4 | 2012 | 565 | 0.220 |
Why?
|
Health Policy | 1 | 2015 | 2662 | 0.220 |
Why?
|
Adult | 81 | 2024 | 213889 | 0.220 |
Why?
|
Meningoencephalitis | 2 | 2018 | 78 | 0.210 |
Why?
|
West Nile Fever | 2 | 2017 | 78 | 0.210 |
Why?
|
Neuroschistosomiasis | 1 | 2001 | 3 | 0.210 |
Why?
|
Critical Care | 1 | 2015 | 2647 | 0.210 |
Why?
|
Blood Flow Velocity | 4 | 2011 | 1423 | 0.210 |
Why?
|
Imaging, Three-Dimensional | 4 | 2023 | 4033 | 0.200 |
Why?
|
Inpatients | 2 | 2024 | 2515 | 0.200 |
Why?
|
Spin Labels | 2 | 2021 | 332 | 0.200 |
Why?
|
Craniocerebral Trauma | 2 | 2010 | 482 | 0.200 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2022 | 89 | 0.200 |
Why?
|
Leukoencephalopathies | 2 | 2021 | 238 | 0.190 |
Why?
|
Bipolar Disorder | 1 | 2018 | 5027 | 0.190 |
Why?
|
Arterial Occlusive Diseases | 3 | 2018 | 793 | 0.190 |
Why?
|
Relapsing Fever | 1 | 2020 | 19 | 0.190 |
Why?
|
Borrelia | 1 | 2020 | 67 | 0.190 |
Why?
|
Infarction, Middle Cerebral Artery | 4 | 2012 | 476 | 0.180 |
Why?
|
Mycobacterium bovis | 1 | 2021 | 150 | 0.180 |
Why?
|
Prognosis | 17 | 2023 | 29052 | 0.180 |
Why?
|
Cerebral Cortex | 4 | 2014 | 5692 | 0.180 |
Why?
|
Angiography, Digital Subtraction | 2 | 2019 | 341 | 0.180 |
Why?
|
Carotid Arteries | 2 | 2018 | 949 | 0.180 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2019 | 42 | 0.170 |
Why?
|
ROC Curve | 6 | 2014 | 3527 | 0.170 |
Why?
|
Diagnostic Errors | 3 | 2015 | 1256 | 0.170 |
Why?
|
Wounds, Nonpenetrating | 2 | 2010 | 795 | 0.170 |
Why?
|
Fever | 4 | 2022 | 1616 | 0.170 |
Why?
|
Academic Medical Centers | 5 | 2021 | 2760 | 0.170 |
Why?
|
Comparative Effectiveness Research | 2 | 2014 | 680 | 0.170 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2014 | 781 | 0.170 |
Why?
|
Collateral Circulation | 2 | 2017 | 287 | 0.160 |
Why?
|
Carcinoma | 2 | 2007 | 2375 | 0.160 |
Why?
|
Practice Guidelines as Topic | 4 | 2016 | 7270 | 0.160 |
Why?
|
Brain Injuries | 5 | 2021 | 2029 | 0.160 |
Why?
|
Disability Evaluation | 2 | 2009 | 1828 | 0.160 |
Why?
|
Persistent Vegetative State | 1 | 2020 | 260 | 0.150 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2019 | 138 | 0.150 |
Why?
|
Roseolovirus Infections | 1 | 2018 | 45 | 0.150 |
Why?
|
Night Care | 1 | 2017 | 28 | 0.150 |
Why?
|
Carotid Artery, Internal | 4 | 2015 | 445 | 0.150 |
Why?
|
Herpesvirus 6, Human | 1 | 2018 | 95 | 0.150 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2022 | 339 | 0.150 |
Why?
|
Septins | 1 | 2016 | 52 | 0.140 |
Why?
|
Hemorrhage | 1 | 2009 | 3458 | 0.140 |
Why?
|
Microvessels | 1 | 2021 | 544 | 0.140 |
Why?
|
Software | 2 | 2009 | 4440 | 0.130 |
Why?
|
Recovery of Function | 3 | 2021 | 2922 | 0.130 |
Why?
|
Blood Volume Determination | 2 | 2012 | 43 | 0.130 |
Why?
|
Medical Staff, Hospital | 1 | 2020 | 601 | 0.130 |
Why?
|
Follow-Up Studies | 12 | 2015 | 39001 | 0.130 |
Why?
|
Lumbosacral Region | 1 | 2017 | 310 | 0.130 |
Why?
|
Encephalomyelitis, Eastern Equine | 2 | 2008 | 15 | 0.130 |
Why?
|
Educational Status | 1 | 2023 | 2540 | 0.130 |
Why?
|
Purpura | 1 | 1996 | 122 | 0.130 |
Why?
|
Oxygen Inhalation Therapy | 3 | 2010 | 367 | 0.130 |
Why?
|
Hepatic Encephalopathy | 1 | 2016 | 139 | 0.130 |
Why?
|
Compensation and Redress | 1 | 2015 | 71 | 0.130 |
Why?
|
Regional Blood Flow | 4 | 2008 | 1525 | 0.130 |
Why?
|
Injections, Intra-Arterial | 2 | 2006 | 193 | 0.130 |
Why?
|
Middle Cerebral Artery | 2 | 2015 | 264 | 0.130 |
Why?
|
Neck | 1 | 2019 | 698 | 0.130 |
Why?
|
Brain Stem | 3 | 2014 | 844 | 0.130 |
Why?
|
Subarachnoid Hemorrhage | 2 | 1999 | 1018 | 0.130 |
Why?
|
Biliary Tract Neoplasms | 1 | 2016 | 178 | 0.130 |
Why?
|
Medulla Oblongata | 1 | 2016 | 243 | 0.130 |
Why?
|
Astrocytoma | 2 | 2013 | 790 | 0.130 |
Why?
|
Liver Failure, Acute | 1 | 2016 | 165 | 0.120 |
Why?
|
Endovascular Procedures | 3 | 2021 | 1980 | 0.120 |
Why?
|
Tissue Plasminogen Activator | 3 | 2013 | 1263 | 0.120 |
Why?
|
Gadolinium DTPA | 2 | 2011 | 836 | 0.120 |
Why?
|
Statistics, Nonparametric | 2 | 2010 | 2883 | 0.120 |
Why?
|
Motion | 3 | 2023 | 798 | 0.120 |
Why?
|
Tomography | 1 | 1996 | 389 | 0.120 |
Why?
|
Efficiency | 1 | 2017 | 462 | 0.120 |
Why?
|
Fellowships and Scholarships | 3 | 2016 | 1077 | 0.120 |
Why?
|
Renal Insufficiency | 3 | 2021 | 805 | 0.120 |
Why?
|
Faculty, Medical | 2 | 2020 | 1181 | 0.120 |
Why?
|
Cardiac Volume | 1 | 2014 | 210 | 0.120 |
Why?
|
Head | 1 | 2019 | 878 | 0.120 |
Why?
|
Accidental Falls | 1 | 2022 | 1062 | 0.120 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2022 | 980 | 0.120 |
Why?
|
Personality Disorders | 1 | 2018 | 713 | 0.120 |
Why?
|
Paresis | 2 | 2012 | 180 | 0.120 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2014 | 1209 | 0.120 |
Why?
|
Governing Board | 1 | 2013 | 53 | 0.110 |
Why?
|
Heart Arrest | 1 | 2023 | 1470 | 0.110 |
Why?
|
United States | 15 | 2021 | 69859 | 0.110 |
Why?
|
Alcohol Withdrawal Seizures | 1 | 2012 | 10 | 0.110 |
Why?
|
Hyperplasia | 2 | 2013 | 1185 | 0.110 |
Why?
|
United States Dept. of Health and Human Services | 1 | 2013 | 90 | 0.110 |
Why?
|
Hematoma, Subdural | 1 | 2013 | 126 | 0.110 |
Why?
|
Leukoaraiosis | 2 | 2019 | 118 | 0.110 |
Why?
|
Alcohol Withdrawal Delirium | 1 | 2012 | 27 | 0.110 |
Why?
|
Peer Review | 1 | 2015 | 209 | 0.110 |
Why?
|
Adolescent | 26 | 2020 | 85729 | 0.110 |
Why?
|
Time Factors | 17 | 2017 | 40038 | 0.110 |
Why?
|
Immunocompromised Host | 1 | 2018 | 847 | 0.110 |
Why?
|
Treatment Outcome | 18 | 2017 | 63042 | 0.110 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 1999 | 859 | 0.110 |
Why?
|
Single-Blind Method | 2 | 2014 | 1586 | 0.110 |
Why?
|
Pituitary Neoplasms | 2 | 2011 | 1345 | 0.110 |
Why?
|
Cerebrospinal Fluid | 3 | 2020 | 533 | 0.100 |
Why?
|
Risk Factors | 14 | 2023 | 72252 | 0.100 |
Why?
|
Nelson Syndrome | 1 | 2011 | 20 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3134 | 0.100 |
Why?
|
Vascular Neoplasms | 1 | 2013 | 175 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.100 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2013 | 145 | 0.100 |
Why?
|
Young Adult | 15 | 2023 | 56392 | 0.100 |
Why?
|
West Nile virus | 2 | 2017 | 79 | 0.100 |
Why?
|
Patient Discharge | 1 | 2004 | 3317 | 0.100 |
Why?
|
Health Services Research | 1 | 2019 | 1836 | 0.100 |
Why?
|
Adrenal Cortex | 1 | 2011 | 140 | 0.100 |
Why?
|
Artificial Limbs | 1 | 2012 | 123 | 0.100 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 1060 | 0.100 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2011 | 103 | 0.100 |
Why?
|
Critical Pathways | 1 | 2015 | 476 | 0.100 |
Why?
|
Magnetics | 1 | 2014 | 604 | 0.100 |
Why?
|
Iopamidol | 1 | 2011 | 191 | 0.100 |
Why?
|
Observer Variation | 6 | 2012 | 2592 | 0.100 |
Why?
|
Hepatitis B | 1 | 2016 | 693 | 0.090 |
Why?
|
Waldenstrom Macroglobulinemia | 2 | 2011 | 1052 | 0.090 |
Why?
|
Intensive Care Units | 2 | 2021 | 3679 | 0.090 |
Why?
|
Malpractice | 1 | 2015 | 572 | 0.090 |
Why?
|
Ultrasonography | 3 | 2019 | 5986 | 0.090 |
Why?
|
Radiation Injuries | 2 | 2010 | 1180 | 0.090 |
Why?
|
Adenoma | 2 | 2011 | 2173 | 0.090 |
Why?
|
Child | 17 | 2019 | 77637 | 0.090 |
Why?
|
Multiple Trauma | 1 | 2012 | 367 | 0.090 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2009 | 42 | 0.090 |
Why?
|
Cerebral Veins | 1 | 2011 | 156 | 0.090 |
Why?
|
Lumbar Vertebrae | 2 | 2017 | 1848 | 0.090 |
Why?
|
Medicare | 4 | 2015 | 6565 | 0.090 |
Why?
|
Hematoma, Subdural, Intracranial | 1 | 2009 | 33 | 0.090 |
Why?
|
Radiology, Interventional | 1 | 2013 | 460 | 0.090 |
Why?
|
Scalp | 1 | 2012 | 378 | 0.090 |
Why?
|
Meglumine | 1 | 2009 | 149 | 0.090 |
Why?
|
Advisory Committees | 1 | 2013 | 775 | 0.090 |
Why?
|
Adrenal Glands | 1 | 2011 | 547 | 0.080 |
Why?
|
Phlebography | 1 | 2010 | 333 | 0.080 |
Why?
|
Encephalitis Virus, Eastern Equine | 1 | 2008 | 9 | 0.080 |
Why?
|
Health Promotion | 1 | 2021 | 2205 | 0.080 |
Why?
|
Skull Fractures | 1 | 2010 | 195 | 0.080 |
Why?
|
Hospitals, General | 1 | 2013 | 749 | 0.080 |
Why?
|
Cerebellar Neoplasms | 1 | 2013 | 587 | 0.080 |
Why?
|
Tuberculosis | 1 | 2021 | 1914 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1968 | 0.080 |
Why?
|
Trauma Severity Indices | 1 | 2009 | 481 | 0.080 |
Why?
|
Adenocarcinoma | 3 | 2016 | 6363 | 0.080 |
Why?
|
Statistics as Topic | 3 | 2012 | 2369 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2020 | 3758 | 0.080 |
Why?
|
Acromegaly | 1 | 2010 | 348 | 0.070 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 2419 | 0.070 |
Why?
|
Accidents, Traffic | 1 | 2012 | 819 | 0.070 |
Why?
|
Communication | 1 | 2021 | 3748 | 0.070 |
Why?
|
Vasospasm, Intracranial | 1 | 2009 | 208 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2021 | 3079 | 0.070 |
Why?
|
Lyme Neuroborreliosis | 1 | 2007 | 51 | 0.070 |
Why?
|
Hospital Mortality | 2 | 2011 | 5316 | 0.070 |
Why?
|
Extremities | 1 | 2012 | 867 | 0.070 |
Why?
|
Puerperal Disorders | 1 | 2009 | 275 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2837 | 0.070 |
Why?
|
Pandemics | 3 | 2021 | 8385 | 0.070 |
Why?
|
Organometallic Compounds | 1 | 2009 | 665 | 0.070 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2014 | 1265 | 0.070 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2005 | 25 | 0.070 |
Why?
|
Borrelia burgdorferi | 1 | 2007 | 180 | 0.060 |
Why?
|
Seizures | 4 | 2012 | 2850 | 0.060 |
Why?
|
Neurology | 1 | 2013 | 764 | 0.060 |
Why?
|
Child, Preschool | 9 | 2019 | 40964 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 7908 | 0.060 |
Why?
|
Iohexol | 1 | 2006 | 196 | 0.060 |
Why?
|
Human Growth Hormone | 1 | 2010 | 684 | 0.060 |
Why?
|
Surgical Instruments | 1 | 2007 | 395 | 0.060 |
Why?
|
Meningioma | 2 | 2012 | 1209 | 0.060 |
Why?
|
Prospective Studies | 12 | 2021 | 53250 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2014 | 12243 | 0.060 |
Why?
|
Aneurysm | 1 | 2007 | 339 | 0.060 |
Why?
|
Brain Abscess | 1 | 2005 | 119 | 0.060 |
Why?
|
Hypertension | 4 | 2019 | 8480 | 0.060 |
Why?
|
Emergency Service, Hospital | 3 | 2021 | 7658 | 0.060 |
Why?
|
Infertility, Female | 1 | 2010 | 788 | 0.060 |
Why?
|
Patient Admission | 1 | 2011 | 1380 | 0.060 |
Why?
|
Periodicals as Topic | 1 | 2015 | 1429 | 0.060 |
Why?
|
Hydrocortisone | 1 | 2011 | 1826 | 0.060 |
Why?
|
Health Care Reform | 1 | 2013 | 1261 | 0.060 |
Why?
|
Encephalitis | 2 | 2017 | 424 | 0.060 |
Why?
|
Thalamus | 2 | 2000 | 1023 | 0.060 |
Why?
|
Brain Damage, Chronic | 1 | 2004 | 263 | 0.060 |
Why?
|
Corpus Callosum | 2 | 2005 | 736 | 0.060 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2004 | 102 | 0.060 |
Why?
|
Body Water | 1 | 2004 | 343 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2005 | 11524 | 0.050 |
Why?
|
Deoxycytidine | 2 | 2005 | 826 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3089 | 0.050 |
Why?
|
Cohort Studies | 9 | 2016 | 40545 | 0.050 |
Why?
|
Videoconferencing | 1 | 2004 | 196 | 0.050 |
Why?
|
Time | 1 | 2024 | 542 | 0.050 |
Why?
|
Oligodendroglioma | 1 | 2004 | 279 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2014 | 3817 | 0.050 |
Why?
|
Remote Consultation | 1 | 2004 | 239 | 0.050 |
Why?
|
Ventricular Function, Left | 1 | 2014 | 3660 | 0.050 |
Why?
|
Motor Activity | 1 | 2012 | 2714 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16361 | 0.050 |
Why?
|
Spectrum Analysis | 1 | 2024 | 454 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2012 | 9239 | 0.050 |
Why?
|
Orbital Neoplasms | 1 | 2004 | 225 | 0.050 |
Why?
|
Documentation | 1 | 2007 | 871 | 0.050 |
Why?
|
Amnesia, Transient Global | 1 | 2001 | 22 | 0.050 |
Why?
|
Burns | 1 | 2012 | 1815 | 0.050 |
Why?
|
Comorbidity | 6 | 2012 | 10380 | 0.050 |
Why?
|
Leadership | 2 | 2021 | 1357 | 0.050 |
Why?
|
Biopsy | 4 | 2019 | 6750 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6237 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2010 | 2016 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2012 | 3510 | 0.050 |
Why?
|
Boronic Acids | 1 | 2005 | 965 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3608 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2018 | 1596 | 0.050 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2001 | 124 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2024 | 2556 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2017 | 1459 | 0.050 |
Why?
|
Radiotherapy, Conformal | 1 | 2004 | 548 | 0.050 |
Why?
|
False Positive Reactions | 1 | 2002 | 980 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5445 | 0.040 |
Why?
|
Medicaid | 1 | 2013 | 2736 | 0.040 |
Why?
|
Subarachnoid Space | 1 | 1999 | 79 | 0.040 |
Why?
|
Syndrome | 2 | 2009 | 3249 | 0.040 |
Why?
|
Survival Rate | 3 | 2009 | 12786 | 0.040 |
Why?
|
Pyrazines | 1 | 2005 | 1230 | 0.040 |
Why?
|
Speech Disorders | 1 | 2020 | 190 | 0.040 |
Why?
|
Metabolic Clearance Rate | 1 | 1999 | 380 | 0.040 |
Why?
|
Pilot Projects | 5 | 2012 | 8316 | 0.040 |
Why?
|
Relative Value Scales | 1 | 2019 | 84 | 0.040 |
Why?
|
Career Choice | 1 | 2005 | 743 | 0.040 |
Why?
|
Medical Records | 1 | 2004 | 1412 | 0.040 |
Why?
|
Massachusetts | 4 | 2013 | 8660 | 0.040 |
Why?
|
Craniotomy | 2 | 2014 | 729 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2000 | 377 | 0.040 |
Why?
|
Disease Progression | 7 | 2014 | 13273 | 0.040 |
Why?
|
Mutism | 1 | 1998 | 24 | 0.040 |
Why?
|
Foscarnet | 1 | 2018 | 38 | 0.040 |
Why?
|
Intracranial Embolism | 1 | 2000 | 202 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2715 | 0.040 |
Why?
|
Genetic Counseling | 1 | 2022 | 600 | 0.040 |
Why?
|
Aneurysm, False | 1 | 2021 | 276 | 0.040 |
Why?
|
Graft vs Host Reaction | 1 | 2018 | 104 | 0.040 |
Why?
|
Whole Body Imaging | 1 | 2010 | 282 | 0.040 |
Why?
|
Intracranial Hypotension | 1 | 1998 | 42 | 0.040 |
Why?
|
Shock | 1 | 2020 | 318 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 735 | 0.040 |
Why?
|
Time and Motion Studies | 1 | 2017 | 149 | 0.040 |
Why?
|
Security Measures | 1 | 2017 | 77 | 0.040 |
Why?
|
Nerve Fibers, Myelinated | 3 | 2009 | 957 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2008 | 3175 | 0.040 |
Why?
|
Animals | 5 | 2017 | 168660 | 0.040 |
Why?
|
Decerebrate State | 1 | 2016 | 42 | 0.040 |
Why?
|
Attitude of Health Personnel | 2 | 2014 | 3839 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2020 | 559 | 0.040 |
Why?
|
Prevalence | 5 | 2012 | 15211 | 0.040 |
Why?
|
Schistosomiasis mansoni | 1 | 1997 | 85 | 0.040 |
Why?
|
Calcinosis | 2 | 2009 | 1495 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2001 | 652 | 0.030 |
Why?
|
Plasmacytoma | 1 | 1997 | 183 | 0.030 |
Why?
|
Area Under Curve | 2 | 2011 | 1654 | 0.030 |
Why?
|
Dura Mater | 1 | 1998 | 291 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1676 | 0.030 |
Why?
|
Hepatitis, Viral, Human | 1 | 2016 | 138 | 0.030 |
Why?
|
Circle of Willis | 1 | 2015 | 68 | 0.030 |
Why?
|
Infant | 7 | 2019 | 35122 | 0.030 |
Why?
|
Anterior Cerebral Artery | 1 | 2015 | 48 | 0.030 |
Why?
|
Radionuclide Imaging | 2 | 1998 | 2034 | 0.030 |
Why?
|
Oxygen | 2 | 2024 | 4189 | 0.030 |
Why?
|
Curriculum | 2 | 2021 | 3603 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2002 | 1018 | 0.030 |
Why?
|
Adenoma, Islet Cell | 1 | 1995 | 82 | 0.030 |
Why?
|
Olfaction Disorders | 1 | 1997 | 222 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2023 | 2479 | 0.030 |
Why?
|
DiGeorge Syndrome | 1 | 1996 | 177 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2016 | 529 | 0.030 |
Why?
|
Gallbladder | 1 | 2016 | 302 | 0.030 |
Why?
|
Medicare Payment Advisory Commission | 1 | 2014 | 14 | 0.030 |
Why?
|
Aortic Diseases | 1 | 2021 | 743 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 816 | 0.030 |
Why?
|
Dapsone | 1 | 1994 | 54 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 2021 | 1084 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2020 | 915 | 0.030 |
Why?
|
Gastric Acid | 1 | 1994 | 104 | 0.030 |
Why?
|
Causality | 2 | 2012 | 1275 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3503 | 0.030 |
Why?
|
Antacids | 1 | 1994 | 99 | 0.030 |
Why?
|
Thalamic Diseases | 1 | 2013 | 16 | 0.030 |
Why?
|
Unconsciousness | 1 | 2016 | 263 | 0.030 |
Why?
|
Autopsy | 1 | 2018 | 1020 | 0.030 |
Why?
|
Liability, Legal | 1 | 2015 | 213 | 0.030 |
Why?
|
Telephone | 1 | 2017 | 617 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 2012 | 2274 | 0.030 |
Why?
|
Electroencephalography | 3 | 2020 | 6061 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1146 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1488 | 0.030 |
Why?
|
Research Design | 1 | 2009 | 5983 | 0.030 |
Why?
|
Management Audit | 1 | 2013 | 23 | 0.030 |
Why?
|
Encephalitis, Viral | 1 | 2013 | 55 | 0.030 |
Why?
|
Necrosis | 2 | 2010 | 1642 | 0.030 |
Why?
|
Pancreatic Neoplasms | 2 | 2005 | 5264 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1530 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 1994 | 420 | 0.030 |
Why?
|
Boston | 3 | 2011 | 9310 | 0.030 |
Why?
|
Prisoners | 1 | 2016 | 297 | 0.030 |
Why?
|
Writing | 1 | 2015 | 206 | 0.030 |
Why?
|
Emergencies | 1 | 2019 | 1170 | 0.030 |
Why?
|
Vasodilation | 1 | 1997 | 944 | 0.030 |
Why?
|
Government Agencies | 1 | 2013 | 156 | 0.030 |
Why?
|
Epirubicin | 2 | 2003 | 80 | 0.030 |
Why?
|
Diplopia | 1 | 2014 | 200 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2012 | 5691 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2000 | 1656 | 0.030 |
Why?
|
Smoke Inhalation Injury | 1 | 2012 | 48 | 0.030 |
Why?
|
Breast Neoplasms | 3 | 2007 | 20827 | 0.030 |
Why?
|
Age Distribution | 2 | 2009 | 2899 | 0.030 |
Why?
|
Alberta | 1 | 2012 | 64 | 0.030 |
Why?
|
Sarcoidosis | 1 | 1997 | 506 | 0.030 |
Why?
|
Hypercalcemia | 1 | 1995 | 409 | 0.030 |
Why?
|
Heart Valve Diseases | 1 | 2000 | 1073 | 0.030 |
Why?
|
Risk Assessment | 5 | 2012 | 23327 | 0.020 |
Why?
|
Decision Trees | 1 | 2013 | 506 | 0.020 |
Why?
|
Mitral Valve | 1 | 2000 | 1491 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 2005 | 1422 | 0.020 |
Why?
|
Cost Control | 1 | 2013 | 624 | 0.020 |
Why?
|
Accreditation | 1 | 2014 | 452 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2013 | 15281 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2012 | 528 | 0.020 |
Why?
|
Family | 1 | 2022 | 3144 | 0.020 |
Why?
|
Hysterosalpingography | 1 | 2010 | 30 | 0.020 |
Why?
|
Adrenal Gland Diseases | 1 | 2011 | 138 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 636 | 0.020 |
Why?
|
Anisotropy | 2 | 2004 | 1263 | 0.020 |
Why?
|
Psychomotor Agitation | 1 | 2012 | 293 | 0.020 |
Why?
|
Oligomenorrhea | 1 | 2010 | 45 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 1996 | 782 | 0.020 |
Why?
|
Vision Disorders | 1 | 1997 | 1055 | 0.020 |
Why?
|
Movement | 1 | 2017 | 1471 | 0.020 |
Why?
|
Health Care Rationing | 1 | 2013 | 437 | 0.020 |
Why?
|
Lung | 2 | 2021 | 9858 | 0.020 |
Why?
|
Putamen | 1 | 2011 | 291 | 0.020 |
Why?
|
Radiotherapy | 2 | 2010 | 1533 | 0.020 |
Why?
|
Spinal Cord | 2 | 2011 | 1809 | 0.020 |
Why?
|
Sella Turcica | 1 | 2010 | 119 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2011 | 648 | 0.020 |
Why?
|
Washington | 1 | 2010 | 314 | 0.020 |
Why?
|
Adrenalectomy | 1 | 2011 | 342 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 2011 | 392 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1653 | 0.020 |
Why?
|
Neurosurgery | 1 | 2016 | 643 | 0.020 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2011 | 176 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4777 | 0.020 |
Why?
|
Neural Pathways | 1 | 2020 | 2971 | 0.020 |
Why?
|
Delirium | 1 | 2021 | 1611 | 0.020 |
Why?
|
Hospital Information Systems | 1 | 1972 | 395 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2568 | 0.020 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2010 | 337 | 0.020 |
Why?
|
Computers | 1 | 1972 | 602 | 0.020 |
Why?
|
Jugular Veins | 1 | 2010 | 204 | 0.020 |
Why?
|
Hypoglycemia | 1 | 2016 | 861 | 0.020 |
Why?
|
Headache Disorders, Primary | 1 | 2009 | 36 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2528 | 0.020 |
Why?
|
Disease Vectors | 1 | 2008 | 60 | 0.020 |
Why?
|
Canada | 1 | 2014 | 2064 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3617 | 0.020 |
Why?
|
Thymoma | 1 | 1990 | 186 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2019 | 2305 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 962 | 0.020 |
Why?
|
Health Services | 1 | 1993 | 758 | 0.020 |
Why?
|
Myasthenia Gravis | 1 | 1990 | 199 | 0.020 |
Why?
|
Fluorouracil | 2 | 2003 | 1619 | 0.020 |
Why?
|
Thymus Neoplasms | 1 | 1990 | 268 | 0.020 |
Why?
|
Endometrium | 1 | 2010 | 423 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2019 | 1518 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2011 | 885 | 0.020 |
Why?
|
Catheterization, Peripheral | 1 | 2010 | 345 | 0.020 |
Why?
|
Cranial Nerve Diseases | 1 | 2007 | 112 | 0.020 |
Why?
|
Cyclophosphamide | 2 | 2003 | 2241 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2010 | 370 | 0.020 |
Why?
|
Weight Loss | 1 | 2017 | 2625 | 0.020 |
Why?
|
Vasoconstriction | 1 | 2009 | 597 | 0.020 |
Why?
|
Brain Mapping | 1 | 2001 | 6622 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2012 | 2103 | 0.020 |
Why?
|
Kidney Diseases, Cystic | 1 | 1967 | 186 | 0.020 |
Why?
|
Logistic Models | 2 | 2011 | 13404 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2001 | 25609 | 0.020 |
Why?
|
Paralysis | 1 | 2007 | 247 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13980 | 0.020 |
Why?
|
Bacterial Infections | 2 | 2008 | 1400 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2018 | 2984 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2736 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.020 |
Why?
|
Reference Standards | 1 | 2009 | 1023 | 0.020 |
Why?
|
Radiopharmaceuticals | 2 | 2010 | 2647 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2007 | 576 | 0.020 |
Why?
|
Hemodynamics | 1 | 2014 | 4197 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2013 | 1392 | 0.010 |
Why?
|
Attitude to Health | 1 | 1993 | 2052 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3645 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 2004 | 228 | 0.010 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 875 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2008 | 1537 | 0.010 |
Why?
|
Microcirculation | 1 | 2008 | 1287 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1972 | 1171 | 0.010 |
Why?
|
Blood Pressure | 1 | 1998 | 8551 | 0.010 |
Why?
|
Hyperoxia | 1 | 2005 | 262 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4286 | 0.010 |
Why?
|
Postoperative Period | 1 | 2007 | 1841 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2004 | 626 | 0.010 |
Why?
|
Incidence | 2 | 2011 | 20948 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1998 | 1677 | 0.010 |
Why?
|
Lactic Acid | 1 | 2007 | 1131 | 0.010 |
Why?
|
Virus Diseases | 1 | 2008 | 711 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2037 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 13691 | 0.010 |
Why?
|
Alcoholism | 1 | 2012 | 1907 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8090 | 0.010 |
Why?
|
Societies, Medical | 1 | 2014 | 3740 | 0.010 |
Why?
|
Pregnancy | 2 | 2009 | 29140 | 0.010 |
Why?
|
Cough | 1 | 2005 | 555 | 0.010 |
Why?
|
Aging | 2 | 2008 | 8655 | 0.010 |
Why?
|
Survival Analysis | 2 | 2005 | 10251 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2776 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2005 | 1588 | 0.010 |
Why?
|
Antigens, Viral | 1 | 2005 | 1035 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2012 | 2002 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2007 | 1470 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6356 | 0.010 |
Why?
|
Age Factors | 2 | 2012 | 18355 | 0.010 |
Why?
|
Brain Stem Infarctions | 1 | 1999 | 32 | 0.010 |
Why?
|
Central Nervous System | 1 | 2007 | 1358 | 0.010 |
Why?
|
Cerebral Arterial Diseases | 1 | 1999 | 82 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9944 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 1993 | 3020 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2007 | 1178 | 0.010 |
Why?
|
Decision Making | 1 | 1993 | 3887 | 0.010 |
Why?
|
Subdural Effusion | 1 | 1998 | 19 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11360 | 0.010 |
Why?
|
Indium Radioisotopes | 1 | 1998 | 118 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2004 | 2971 | 0.010 |
Why?
|
Blood Patch, Epidural | 1 | 1998 | 59 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2001 | 640 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2001 | 690 | 0.010 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2001 | 627 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29777 | 0.010 |
Why?
|
Epidural Space | 1 | 1998 | 124 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2003 | 10940 | 0.010 |
Why?
|
Central Nervous System Neoplasms | 1 | 2005 | 895 | 0.010 |
Why?
|
Paranasal Sinus Diseases | 1 | 1997 | 116 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 7729 | 0.010 |
Why?
|
Pain | 2 | 2007 | 4987 | 0.010 |
Why?
|
Schistosoma mansoni | 1 | 1997 | 149 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2007 | 2899 | 0.010 |
Why?
|
Ischemia | 1 | 2005 | 1907 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 1996 | 351 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7172 | 0.010 |
Why?
|
Computer Simulation | 1 | 2009 | 6188 | 0.010 |
Why?
|
Spinal Cord Neoplasms | 1 | 1998 | 281 | 0.010 |
Why?
|
Emergency Medicine | 1 | 2004 | 1205 | 0.010 |
Why?
|
Water | 1 | 2001 | 1394 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2005 | 4848 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2003 | 3480 | 0.010 |
Why?
|
Posture | 1 | 1998 | 957 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2007 | 4665 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 4931 | 0.010 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 1995 | 331 | 0.010 |
Why?
|
Patient Compliance | 1 | 2003 | 2683 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 1996 | 1396 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 8637 | 0.010 |
Why?
|
Kidney | 1 | 1967 | 7185 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 1998 | 1027 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 1994 | 599 | 0.010 |
Why?
|
Drug Interactions | 1 | 1994 | 1460 | 0.010 |
Why?
|
Thymectomy | 1 | 1990 | 191 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 1996 | 1416 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 1994 | 2029 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2001 | 3587 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 1995 | 1800 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1998 | 5078 | 0.000 |
Why?
|
Odds Ratio | 1 | 2000 | 9848 | 0.000 |
Why?
|
Disease | 1 | 1993 | 680 | 0.000 |
Why?
|
Echocardiography | 1 | 1999 | 5096 | 0.000 |
Why?
|
Heart Diseases | 1 | 1999 | 2789 | 0.000 |
Why?
|
Neurologic Manifestations | 1 | 1966 | 20 | 0.000 |
Why?
|
Cleidocranial Dysplasia | 1 | 1966 | 19 | 0.000 |
Why?
|
Aortography | 1 | 1967 | 437 | 0.000 |
Why?
|
Fear | 1 | 1993 | 1438 | 0.000 |
Why?
|
Atrial Fibrillation | 1 | 2001 | 5033 | 0.000 |
Why?
|
Neoplasm Proteins | 1 | 1995 | 3706 | 0.000 |
Why?
|
Adaptation, Psychological | 1 | 1993 | 2575 | 0.000 |
Why?
|
Proteins | 1 | 1995 | 6098 | 0.000 |
Why?
|
Chronic Disease | 1 | 1993 | 9139 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1967 | 2146 | 0.000 |
Why?
|